Did you know that alcohol works on the GABA system? Such intricate mechanisms and their implications for brain research are the focus of our insightful conversation with David Nutt. A pioneer in the field of psychopharmacology, David's groundbreaking work opens up intriguing possibilities for treating disorders like addiction, depression, and anxiety. We walk through David's journey, from his surprising discoveries to the complex tensions he navigated when making policy suggestions to reduce alcohol’s harms.

Our candid chat with David takes us down memory lane to when he chaired the Home Office Advisory Council's scientific committee and the palpable shift in his life. We delve into the dichotomy of alcohol, seen as one of the most harmful drugs, yet legal, and the ripple effects of alcohol advertising on underage drinking. Pioneering research by Lachmayr and Jürgen Rehm is put under the microscope as we explore the startling link between alcohol and at least seven types of cancer, with an added focus on cirrhosis of the liver.

The conversation takes a thrilling turn as we dissect David's efforts in developing Arca-Rell, a promising alcohol-free alternative. In the midst of discussing the nuances of alcohol and potential treatments, we take a deep dive into an emerging trend - the therapeutic use of psychedelics. From their role in anti-war protests to their potential in lifting lifelong depression, we navigate the complex terrain of psychedelics. Join us as David leaves us with invaluable insights from his book, podcast, and charity work. Strap in for a riveting journey through the enthralling world of psychopharmacology.

Learn more about your ad choices. Visit megaphone.fm/adchoices